Medical disclaimer

Acute Liver Failure in Intensive Care: Vienna General Hospital Study

In this Vienna series of 31 patients with acute liver failure, 19 survived intensive care, and those who received an urgent liver transplant had favorable survival. The patients were treated in the intensive care unit of the Department of Gastroenterology and Hepatology at Vienna General Hospital (AKH), which is the clinic this page is about.

8 min read

Prepared by Bookimed editorial team

Medical content and care coordination

Vienna General Hospital (AKH)
← All research summaries
Published research, not an individual patient story.

The source identifies treatment at the named clinic. Study results describe this cohort, not a predicted individual outcome.

Key takeaways

  • The study looked back at all 31 acute liver failure patients admitted to the intensive care unit between 2012 and 2024.
  • Overall ICU survival was 61% (19 of 31 patients).
  • 18 patients did not receive a high-urgency liver transplant, and their ICU survival was 44%.
  • 13 patients received a high-urgency liver transplant, 12 of them survived 28 days, and 6-month overall survival was 85%.
  • These are group results from one center and are not a forecast for any individual patient.

The question this study addresses

This retrospective single-center study, published in Wiener klinische Wochenschrift in 2025, included all adults with acute liver failure (ALF, a rapid loss of liver function) admitted to the ICU of the Department of Gastroenterology and Hepatology at Vienna General Hospital between 2012 and 2024. The patients were treated at this hospital, which is the clinic itself. Median age was 44 years and 20 patients (65%) were female. Causes were viral infections (8 patients), autoimmune hepatitis (5), Wilson's disease (4), drug-induced liver injury (3) and no identified cause (8). Median ICU stay was 12 days. The authors conclude that high-urgency liver transplantation (HU-LTx) was needed in almost half of patients and underscores the role of ICU care and early transfer to transplant centers.

The situation
Adults with acute liver failure who were admitted to an intensive care unit, from several causes including viral infection, autoimmune hepatitis, Wilson's disease and drug-induced liver injury.
The treatment
Intensive care management, with high-urgency liver transplantation (HU-LTx) for 13 of the 31 patients.

What this evidence cannot establish

  • The study is retrospective and covers a single center, so it cannot show that one approach caused better survival than another.
  • The patients were treated at Vienna General Hospital, the same clinic this page is about, but the study is a description of past patients and not a promise of what the clinic will achieve for a new patient.
  • The abstract does not give details on complications or on follow-up after ICU discharge.

Patient groups in the published study

18 patients · Published study group

Acute liver failure managed in intensive care without urgent transplant

Indication
Acute liver failure
Treatment
Intensive care management without high-urgency liver transplantation

18 adult patients in the ICU series who did not receive HU-LTx.

These patients had acute liver failure and were treated in the ICU without an urgent liver transplant.

Intensive care management without high-urgency liver transplantation.

  • ICU survival

    44%

    18 patients · Study group

    ICU stay

Reported risks

  • The abstract reports no adverse events for this group separately; the study-wide ICU length of stay was a median of 12 days.

Limits of this evidence

  • The abstract does not state the causes, follow-up after ICU discharge or complications for this group.

For a clinic assessment

  • Recent liver blood test results and the diagnosis of the cause of liver failure, if known
  • Current medication list and any ICU or hospital discharge summaries

13 patients · Published study group

Acute liver failure treated with urgent liver transplant

Indication
Acute liver failure
Treatment
High-urgency liver transplantation (HU-LTx)

13 adult patients in the ICU series who received HU-LTx.

These patients had acute liver failure and were evaluated for and received a high-urgency liver transplant.

High-urgency liver transplantation (HU-LTx) after admission to the ICU.

  • Survival at 28 days

    12 / 13

    13 patients · Study group

    28 days

  • 6-month overall survival

    85%

    13 patients · Study group

    6 months

Reported risks

  • The abstract reports no adverse events for this group separately; the study-wide ICU length of stay was a median of 12 days.

Limits of this evidence

  • The abstract does not state complications or survival beyond 6 months for this group.

For a clinic assessment

  • Medical records describing the cause and course of liver failure
  • Any transplant evaluation reports and current medication list

Results and limits of the study

Overall ICU survival was 61% (19 of 31 patients). Among the 18 patients without HU-LTx, ICU survival was 44%. Among the 13 patients with HU-LTx, 12 survived 28 days and 6-month overall survival was 85%. The groups were not assigned by the study and differ in ways the abstract does not describe, so the numbers should not be compared as if one treatment caused the difference.

  • Overall ICU survival

    19 / 3161%

    31 patients · Whole cohort

    ICU stay

Risks reported by the source

  • The abstract does not list complications or adverse events. The only study-wide stay measure given is a median ICU stay of 12 days.

Limitations and unknowns

  • Complications in each group are not stated in the abstract.
  • Survival beyond 6 months after transplant is not stated.
  • Follow-up after ICU discharge for patients without transplant is not stated.
  • Outcomes by cause of liver failure are not stated.

What to clarify in your treatment plan

Before booking, ask the clinic whether your records can be reviewed for an acute liver failure assessment and how urgent cases are handled. Clarify what documents the transplant team needs, how contact is arranged in an emergency and who coordinates care after discharge. Ask which costs and services Bookimed's coordinator can confirm in writing.

Vienna General Hospital (AKH): clinic profile

  • The patients in this study were treated in the ICU of the Department of Gastroenterology and Hepatology at Vienna General Hospital, which is the clinic itself.
  • The clinic profile for Vienna General Hospital (AKH) is available on Bookimed.
Vienna General Hospital (AKH)

Vienna General Hospital (AKH)

Vienna, Austria

4.5/5 · 19 Bookimed reviews (current clinic profile)

Michael Trauner: doctor profile

  • Michael Trauner is listed as an author of the study, with an affiliation to the Department of Medicine III, Division of Gastroenterology and Hepatology, Intensive Care Unit 13H1, Medical University of Vienna.
Michael Trauner

Michael Trauner

Gastroenterologist

32 years of experience

Safety and recovery: general information

General patient guidance, provided separately from the case evidence. Follow your treating team's instructions.

Possible side effects

  • Liver transplant surgery can involve bile duct complications, bleeding, blood clots, infection, rejection of the donated liver, failure of the donated liver, and mental confusion or seizures.

    Ask the transplant team how these risks are monitored and managed in your situation.

  • Antirejection medicines can cause side effects such as bone thinning, diabetes, diarrhea, headache, high blood pressure and high cholesterol.

    Ask which side effects to watch for and how they are checked.

  • Some donor livers may not work properly after surgery, and another transplant may then be needed as soon as possible.

    Ask what the plan is if the new liver does not function well.

  • There can be a higher risk of some types of cancer after a transplant.

    Ask about long-term check-ups after transplant.

Recovery and aftercare

  • Full healing after liver transplant surgery may take six months or longer, and some people may resume usual activities or work a few months after surgery.

    Ask the team what recovery time to plan for in your case.

  • Many people may return to work within three months and to all other activities within six to 12 months.

    Individual recovery can differ, so confirm expectations with your doctor.

Suitability and cautions

  • Conditions that may disqualify a person from liver transplant include cancer outside the liver (unless successfully treated), congestive heart failure, dementia, infections that cannot be managed, severe lung disease, severe pulmonary hypertension, severe unmanaged mental health disorders with psychosis and substance use disorders.

    The transplant team decides suitability after assessing each patient.

  • Candidates generally need to be healthy enough for surgery and lifelong medicines, and be willing to follow the transplant team's instructions.

    Ask the clinic how this is assessed.

When to contact the clinic

  • Contact the care team right away with abdominal pain, chest pain, fatigue, fever, decreased urine output, severe headache, shortness of breath, vomiting or yellowing of the eyes or skin.

    Do not wait for a scheduled visit if these appear.

Request a personal plan from the clinic

Ask Vienna General Hospital (AKH) about acute liver failure assessment and liver transplant evaluation

Bookimed's coordinator can send your medical records to the clinic and ask what the team needs to review your case. The clinic then decides on the next steps.

Ask the clinic for a current, itemized quotation. Published evidence does not establish package inclusions or a current price.

Frequently asked questions

Who ran this study and where were the patients treated?

The study was run by authors affiliated with the Medical University of Vienna, including Michael Trauner. The patients were treated in the intensive care unit of the Department of Gastroenterology and Hepatology at Vienna General Hospital, which is the clinic this page is about. Bookimed did not run or fund the study. This page only summarizes the published abstract.

How many patients survived in the study?

Overall ICU survival was 61%, which is 19 of 31 patients. Among 18 patients who did not receive a high-urgency liver transplant, ICU survival was 44%. Among 13 who did, 12 survived 28 days and 6-month overall survival was 85%. These are group results from one center and do not predict what will happen for an individual patient.

What caused acute liver failure in these patients?

Viral infections were the most common cause, in 8 patients (26%), and 8 patients (26%) had no identified cause. Autoimmune hepatitis affected 5 patients (16%), Wilson's disease 4 (13%) and drug-induced liver injury 3 (10%). The authors describe the causes as diverse. The abstract does not give outcomes for each cause separately.

Does this study show that a liver transplant is the right choice for me?

No. The study describes what happened to past patients at one center and cannot say what is right for you. The authors note that high-urgency transplant was associated with favorable survival, but the patients in each group were not chosen at random. A transplant team must assess your own condition, so share your records with the clinic through the Bookimed coordinator.

Sources and scope

This page was prepared from the published abstract of the study and the results extracted from it, with every number checked against that text. Risk and recovery information comes from named medical sources on liver transplant, not from the study.

  1. 1. Haselwanter et al. – Acute liver failure in patients admitted to the intensive care unit-a Viennese retrospective single-center analysis.

    Retrospective single-center series · 2025

    31 adults with acute liver failure admitted to the ICU at Vienna General Hospital, 2012-2024

    Follow-up: ICU stay, 28 days and 6 months after high-urgency transplant

    Only the abstract was used, so details on complications, patient selection and follow-up are not available.

  2. 2. Mayo Clinic
  3. 3. Cleveland Clinic
  4. 4. NHS Blood and Transplant
  5. 5. Vienna General Hospital (AKH) on Bookimed
  6. 6. Michael Trauner on Bookimed

Scope and limitations

  • A research summary is not an individual medical recommendation.
  • Group results describe the study participants, not a forecast for any one patient.

About the editorial team

Bookimed editorial team

Prepared by

Bookimed editorial team

Medical content and care coordination

Bookimed prepares evidence summaries from published medical sources and anonymized care records. The clinic and any doctors named on this page are identified separately in their own sections.

About this page

This page summarizes cited evidence and links to current Bookimed provider profiles. It does not replace an individual diagnosis or treatment plan. Published group results are not a guarantee of your outcome.

Clinic profiles and package availability come from the current Site catalog. Historical costs and research measurements keep their original context.

Report a correction